Vaccine Innovators
Now more than ever, global vaccine innovators need a biomanufacturing partner with the ability to adapt skillfully and the capacity to scale rapidly. Enter Resilience.
FORWARD-FOCUSED VACCINE MANUFACTURING
The industry’s response to COVID-19 has made it clear that vaccines made right – meaning “safe, efficacious and readily available” – will find a market, whether or not they’re in the headlines.
We’re not looking to introduce incremental change; instead, our modular approach to next-generation vaccine manufacturing is designed to integrate novel biological, analytical or process-related technologies that can leapfrog the industry forward.
As your clinical and commercial supply partner in vaccine discovery and development, we will be teaming you up with our experts in live viruses, viral vectors, oncolytic viruses and vectors, potency assays, virus-like particles (VLP), and antigen vaccines. Our capabilities extend to our industry-leading expression systems, which are already proving their mettle in vaccines directed at public health threats.